Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age

NCT05391555 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Opioid Toxicity
Pupillary Miosis
Respiratory Depression

Interventions

DRUG: Remifentanil Hydrochloride
DEVICE: Pupillometry measurement

Sponsor

University of California, San Francisco